Frank Zhang1, Ronac Mamtani1,2, Frank I Scott1,2, David S Goldberg1,2, Kevin Haynes1,3, James D Lewis1,2. 1. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, United States. 2. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States. 3. HealthCore, Inc., Wilmington, DE, United States.
Abstract
BACKGROUND: Prescription drugs are a central component of healthcare worldwide. We investigated changes in drug-prescribing patterns over time in the general population. METHODS: Secular trends were analyzed using 1999-2012 prescription data from The Health Improvement Network. Prevalence of receipt of medication prescriptions was computed by age, sex, and therapeutic category for each calendar year. Spearman correlations were computed to assess change over time. RESULTS: Between 1999 and 2012, the percentage of the population that received at least one medication prescription increased from 64.5% to 69.2% (rho = 0.96, p < 0.001). The percentage of patients receiving prescriptions for one to four unique agents declined from 45.6% to 42.1% (Spearman's rho = -0.98, p < 0.001). Meanwhile, the percentage receiving five to nine and 10 or more unique agents increased from 14.1% to 17.5% (rho = 0.996, p < 0.001) and 4.7% to 9.6% (rho = 1.000, p < 0.001) respectively. Largest increases were seen in use of drugs for gastrointestinal disease among women and cardiovascular disease among men. In 2012, the most commonly used agents were for infection or nervous system drugs, with 32.0% and 28.9% of patients receiving at least one prescription, respectively. CONCLUSIONS: Nearly 70% of the United Kingdom population has received prescriptions for one or more medication with increasing proportions receiving prescriptions for five or more. The high rates of medication use increase the complexity and cost of healthcare. These data can be used for public health planning and to design pharmacoepidemiology and comparative effectiveness studies.
BACKGROUND: Prescription drugs are a central component of healthcare worldwide. We investigated changes in drug-prescribing patterns over time in the general population. METHODS: Secular trends were analyzed using 1999-2012 prescription data from The Health Improvement Network. Prevalence of receipt of medication prescriptions was computed by age, sex, and therapeutic category for each calendar year. Spearman correlations were computed to assess change over time. RESULTS: Between 1999 and 2012, the percentage of the population that received at least one medication prescription increased from 64.5% to 69.2% (rho = 0.96, p < 0.001). The percentage of patients receiving prescriptions for one to four unique agents declined from 45.6% to 42.1% (Spearman's rho = -0.98, p < 0.001). Meanwhile, the percentage receiving five to nine and 10 or more unique agents increased from 14.1% to 17.5% (rho = 0.996, p < 0.001) and 4.7% to 9.6% (rho = 1.000, p < 0.001) respectively. Largest increases were seen in use of drugs for gastrointestinal disease among women and cardiovascular disease among men. In 2012, the most commonly used agents were for infection or nervous system drugs, with 32.0% and 28.9% of patients receiving at least one prescription, respectively. CONCLUSIONS: Nearly 70% of the United Kingdom population has received prescriptions for one or more medication with increasing proportions receiving prescriptions for five or more. The high rates of medication use increase the complexity and cost of healthcare. These data can be used for public health planning and to design pharmacoepidemiology and comparative effectiveness studies.
Authors: James D Lewis; Rita Schinnar; Warren B Bilker; Xingmei Wang; Brian L Strom Journal: Pharmacoepidemiol Drug Saf Date: 2007-04 Impact factor: 2.890
Authors: Kristian B Filion; Lawrence Joseph; Jean-François Boivin; Samy Suissa; James M Brophy Journal: Pharmacoepidemiol Drug Saf Date: 2009-10 Impact factor: 2.890
Authors: E A Chrischilles; D J Foley; R B Wallace; J H Lemke; T P Semla; J T Hanlon; R J Glynn; A M Ostfeld; J M Guralnik Journal: J Gerontol Date: 1992-09
Authors: JoAnn E Manson; Judith Hsia; Karen C Johnson; Jacques E Rossouw; Annlouise R Assaf; Norman L Lasser; Maurizio Trevisan; Henry R Black; Susan R Heckbert; Robert Detrano; Ora L Strickland; Nathan D Wong; John R Crouse; Evan Stein; Mary Cushman Journal: N Engl J Med Date: 2003-08-07 Impact factor: 91.245
Authors: Ravy K Vajravelu; Frank I Scott; Ronac Mamtani; Hongzhe Li; Jason H Moore; James D Lewis Journal: J Am Med Inform Assoc Date: 2018-07-01 Impact factor: 4.497
Authors: Jorge A Zamora-Legoff; Elena Myasoedova; Eric L Matteson; Sara J Achenbach; Cynthia S Crowson Journal: Clin Rheumatol Date: 2016-06-22 Impact factor: 2.980
Authors: Monika P Oktora; Petra Denig; Jens H J Bos; Catharina C M Schuiling-Veninga; Eelko Hak Journal: PLoS One Date: 2019-03-22 Impact factor: 3.240
Authors: Widya N Insani; Cate Whittlesea; Hassan Alwafi; Kenneth K C Man; Sarah Chapman; Li Wei Journal: PLoS One Date: 2021-05-26 Impact factor: 3.240
Authors: Lauren Cadel; Stephanie R Cimino; Teagan Rolf von den Baumen; Kadesha A James; Lisa McCarthy; Sara J T Guilcher Journal: Patient Prefer Adherence Date: 2021-06-16 Impact factor: 2.314